The engineering of a 3T human MRI scanner equipped with 300 mT/m gradients – the strongest gradients ever built for an in vivo human MRI scanner – was a major component of the NIH Blueprint Human Connectome Project (HCP). This effort was motivated by the HCP’s goal of mapping, as completely as possible, the macroscopic structural connections of the in vivo healthy, adult human brain using diffusion tractography. Yet, the 300 mT/m gradient system is well suited to many additional types of diffusion measurements. Here, we present three initial applications of the 300mT/m gradients that fall outside the immediate scope of the HCP. These include: 1) diffusion tractography to study the anatomy of consciousness and the mechanisms of brain recovery following traumatic coma; 2) q-space measurements of axon diameter distributions in the in vivo human brain and 3) postmortem diffusion tractography as an adjunct to standard histopathological analysis. We show that the improved sensitivity and diffusion-resolution provided by the gradients is rapidly enabling human applications of techniques that were previously possible only for in vitro and animal models on small-bore scanners, thereby creating novel opportunities to map the microstructure of the human brain in health and disease.

I n North America most clinical MRI is performed at 1.5 T or 3.0 T, and some research applications have moved to 7.0 T. High field is motivated by higher polarization, promising increased signal-to-noise ratio (SNR), and resolution. However, this causes image distortion, constrained imaging efficiency, increased specific absorption rate, and higher cost. For some applications, low field strength may offer intrinsic advantages (1,2). At low field strength, short T1 and long T2* allow more efficient pulse sequence design; imaging near air-tissue interfaces is improved by virtue of reduced susceptibility gradients; and specific absorption rate is reduced, which can diminish heating of conductive devices and implants, and can eliminate pulse sequence parameter constraints (3). Commercial lower field systems have been largely overlooked as hardware and software have improved over the last 2 decades, and therefore are not well-suited for technically demanding imaging. We developed and evaluated a custom 0.55-T MRI system equipped with contemporary

Purpose Controlled aliasing techniques for simultaneously acquired EPI slices have been shown to significantly increase the temporal efficiency for both diffusion-weighted imaging (DWI) and fMRI studies. The “slice-GRAPPA” (SG) method has been widely used to reconstruct such data. We investigate robust optimization techniques for SG to ensure image reconstruction accuracy through a reduction of leakage artifacts. Methods Split slice-GRAPPA (SP-SG) is proposed as an alternative kernel optimization method. The performance of SP-SG is compared to standard SG using data collected on a spherical phantom and in-vivo on two subjects at 3T. Slice accelerated and non-accelerated data were collected for a spin-echo diffusion weighted acquisition. Signal leakage metrics and time-series SNR were used to quantify the performance of the kernel fitting approaches. Results The SP-SG optimization strategy significantly reduces leakage artifacts for both phantom and in-vivo acquisitions. In addition, a significant boost in time-series SNR for in-vivo diffusion weighted acquisitions with in-plane 2× and slice 3× accelerations was observed with the SP-SG approach. Conclusion By minimizing the influence of leakage artifacts during the training of slice-GRAPPA kernels, we have significantly improved reconstruction accuracy. Our robust kernel fitting strategy should enable better reconstruction accuracy and higher slice-acceleration across many applications.

Purpose To demonstrate acquisition and processing methods for quantitative oxygenation venograms that map in vivo oxygen saturation (SvO2) along cerebral venous vasculature. Methods Regularized quantitative susceptibility mapping (QSM) is used to reconstruct susceptibility values and estimate SvO2 in veins. QSM with ℓ1 and ℓ2 regularization are compared in numerical simulations of vessel structures with known magnetic susceptibility. Dual-echo, flow-compensated phase images are collected in three healthy volunteers to create QSM images. Bright veins in the susceptibility maps are vectorized and used to form a three-dimensional vascular mesh, or venogram, along which to display SvO2 values from QSM. Results Quantitative oxygenation venograms that map SvO2 along brain vessels of arbitrary orientation and geometry are shown in vivo. SvO2 values in major cerebral veins lie within the normal physiological range reported by 15O positron emission tomography. SvO2 from QSM is consistent with previous MR susceptometry methods for vessel segments oriented parallel to the main magnetic field. In vessel simulations, ℓ1 regularization results in less than 10% SvO2 absolute error across all vessel tilt orientations and provides more accurate SvO2 estimation than ℓ2 regularization. Conclusion The proposed analysis of susceptibility images enables reliable mapping of quantitative SvO2 along venograms and may facilitate clinical use of venous oxygenation imaging.

Gamma-aminobutyric acid (GABA) and glutamate (Glu) are the major neurotransmitters in the brain. They are crucial for the functioning of healthy brain and their alteration is a major mechanism in the pathophysiology of many neuro-psychiatric disorders. Magnetic resonance spectroscopy (MRS) is the only way to measure GABA and Glu non-invasively in vivo. GABA detection is particularly challenging and requires special MRS techniques. The most popular is MEscher-GArwood (MEGA) difference editing with single-voxel Point RESolved Spectroscopy (PRESS) localization. This technique has three major limitations: a) MEGA editing is a subtraction technique, hence is very sensitive to scanner instabilities and motion artifacts. b) PRESS is prone to localization errors at high fields (≥3T) that compromise accurate quantification. c) Single-voxel spectroscopy can (similar to a biopsy) only probe average GABA and Glu levels in a single location at a time. To mitigate these problems, we implemented a 3D MEGA-editing MRS imaging sequence with the following three features: a) Real-time motion correction, dynamic shim updates, and selective reacquisition to eliminate subtraction artifacts due to scanner instabilities and subject motion. b) Localization by Adiabatic SElective Refocusing (LASER) to improve the localization accuracy and signal-to-noise ratio. c) K-space encoding via a weighted stack of spirals provides 3D metabolic mapping with flexible scan times. Simulations, phantom and in vivo experiments prove that our MEGA-LASER sequence enables 3D mapping of GABA+ and Glx (Glutamate + Gluatmine), by providing 1.66 times larger signal for the 3.02 ppm multiplet of GABA+ compared to MEGA-PRESS, leading to clinically feasible scan times for 3D brain imaging. Hence, our sequence allows accurate and robust 3D-mapping of brain GABA+ and Glx levels to be performed at clinical 3T MR scanners for use in neuroscience and clinical applications.